share_log

Ginkgo Bioworks | 144: Notice of proposed sale of securities pursuant to Rule 144

Ginkgo Bioworks | 144: Notice of proposed sale of securities pursuant to Rule 144

Ginkgo Bioworks | 144:拟议出售证券
美股sec公告 ·  04/24 09:53
Moomoo AI 已提取核心信息
Ginkgo Bioworks Holdings, Inc. officer Che Austin is set to sell 3,968 Class A shares of the company on 04/24/2024, as per the latest filing. These shares, valued at an aggregate market value of $3,468.82, were originally acquired on 10/07/2022 as part of a restricted stock vesting and were compensation for services rendered to the issuer. This planned sale follows a significant transaction history over the past few months, where a total of 249,984 shares were sold, generating gross proceeds of $298,365.46. The notice of the upcoming sale was filed on the same date as the planned sale, with the instruction for this transaction given on 03/14/2023.
Ginkgo Bioworks Holdings, Inc. officer Che Austin is set to sell 3,968 Class A shares of the company on 04/24/2024, as per the latest filing. These shares, valued at an aggregate market value of $3,468.82, were originally acquired on 10/07/2022 as part of a restricted stock vesting and were compensation for services rendered to the issuer. This planned sale follows a significant transaction history over the past few months, where a total of 249,984 shares were sold, generating gross proceeds of $298,365.46. The notice of the upcoming sale was filed on the same date as the planned sale, with the instruction for this transaction given on 03/14/2023.
最新文件显示,Ginkgo Bioworks Holdings, Inc.高管切·奥斯汀定于2024年4月24日出售该公司的3,968股A类股票。这些股票的总市值为3,468.82美元,最初于2022年7月10日作为限制性股票归属的一部分收购,是对向发行人提供的服务的补偿。此次计划出售遵循了过去几个月的重要交易记录,共出售了249,984股股票,总收益为298,365.46美元。即将进行的出售通知与计划出售的同一天提交,该交易的指示于2023年3月14日发出。
最新文件显示,Ginkgo Bioworks Holdings, Inc.高管切·奥斯汀定于2024年4月24日出售该公司的3,968股A类股票。这些股票的总市值为3,468.82美元,最初于2022年7月10日作为限制性股票归属的一部分收购,是对向发行人提供的服务的补偿。此次计划出售遵循了过去几个月的重要交易记录,共出售了249,984股股票,总收益为298,365.46美元。即将进行的出售通知与计划出售的同一天提交,该交易的指示于2023年3月14日发出。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息